SCHEMBL21362668

SCHEMBL21362668

Cc1ccc(C(=O)c2ccc(C(C)(C)C=O)cc2Br)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.44
AKR1C3 P42330 1/20 0.43
ALDH1A1 P00352 3/20 0.42
LMNA P02545 2/20 0.42
HTT P42858 3/20 0.41
NPC1 O15118 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 3/20 0.39
GAA P10253 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
RXRA P19793 1/20 0.38
SRD5A2 P31213 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
KDM5A P29375 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21362431 0.87 TDP1 (0.40) MAPTALDH1A1LMNAHTTNPC1
SCHEMBL5537953 0.73 TDP1 (0.61) MAPTAKR1C3ALDH1A1LMNANPC1
SCHEMBL20158166 0.73 MAPT (0.43) MAPTAKR1C3ALDH1A1LMNAHTT
SCHEMBL3132601 0.73 AKR1C3 (0.65) MAPTAKR1C3ALDH1A1LMNAHTT
SCHEMBL20157316 0.73 MAPT (0.61) MAPTAKR1C3ALDH1A1LMNAHTT
SCHEMBL28770832 0.73 AKR1C3 (0.56) MAPTAKR1C3ALDH1A1LMNATDP1
SCHEMBL20157816 0.72 MAPT (0.51) MAPTAKR1C3ALDH1A1LMNAHTT
SCHEMBL11476383 0.72 MAPT (0.51) MAPTAKR1C3ALDH1A1LMNAHTT
SCHEMBL20157960 0.72 SRD5A2 (0.49) MAPTAKR1C3ALDH1A1LMNAHTT
SCHEMBL20157547 0.71 MAPT (0.50) MAPTAKR1C3ALDH1A1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed